Trodelvy User Reviews & Ratings
Trodelvy has an average rating of 8.0 out of 10 from a total of 3 reviews on drugclasses.com. 100% of reviewers reported a positive experience, while 0% reported a negative experience.
Condition | Avg. Rating | Reviews | Compare |
---|---|---|---|
Breast Cancer | 3 reviews for Breast Cancer | 79 medications | |
Add your review |
- Elle...
- February 5, 2024
For Breast Cancer "Other than neutropenia and alopecia, my side effects are minimal. I'm in the middle of my treatment plan, still hopeful that this will give me a sustained remission."
- Stage...
- Taken for 1 to 6 months
- April 24, 2024
For Breast Cancer "Horrible paralyzing bone pain. Horrible constipation or diarrhea. Horrible experience. Also, face numbness."
Frequently asked questions
Reviews may be edited to correct grammar/spelling or to remove inappropriate language and content. Reviews that appear to be created by parties with a vested interest are not published. This information is not intended to endorse any particular medication. While these reviews may be helpful, they are not a substitute for the expertise, knowledge, and judgement of healthcare professionals.
More about Trodelvy (sacituzumab govitecan)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous antineoplastics
- Breastfeeding
- En español
For Breast Cancer "I occasionally have slurred speech and difficulty swallowing. It's kind of intermittent. No other side effect except complete alopecia"